GONCX
Price
$37.48
Change
+$0.23 (+0.62%)
Updated
Jun 2 closing price
Net Assets
6.37B
RERFX
Price
$67.93
Change
+$0.36 (+0.53%)
Updated
Jun 2 closing price
Net Assets
136.57B
Interact to see
Advertisement

GONCX vs RERFX

Header iconGONCX vs RERFX Comparison
Open Charts GONCX vs RERFXBanner chart's image
GONCX vs RERFX Comparison Chart in %
View a ticker or compare two or three
VS
GONCX vs. RERFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GONCX is a Buy and RERFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERFX has more cash in the bank: 137B vs. GONCX (6.37B). RERFX pays higher dividends than GONCX: RERFX (2.67) vs GONCX (0.00). GONCX was incepted earlier than RERFX: GONCX (20 years) vs RERFX (24 years). GONCX (2.00) is less costly to investors than RERFX (0.52). GONCX is a more actively managed with annual turnover of: 65.00 vs. RERFX (35.00). RERFX has a lower initial minimum investment than GONCX: RERFX (250) vs GONCX (1000). GONCX annual gain was more profitable for investors over the last year : 25.17 vs. RERFX (15.21). RERFX return over 5 years is better than : -0.27 vs. GONCX (-2.89).
GONCXRERFXGONCX / RERFX
Total Expense Ratio2.000.52385%
Annual Report Gross Expense Ratio2.000.52385%
Fund Existence20 years24 years-
Gain YTD13.39411.704114%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets6.37B137B5%
Annual Yield % from dividends0.002.67-
Returns for 1 year25.1715.21165%
Returns for 3 years66.2933.52198%
Returns for 5 years-2.89-0.271,061%
Returns for 10 years77.9162.47125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCSG20.240.30
+1.50%
Healthcare Services Group
SONY22.790.22
+0.97%
Sony Group Corporation
LNTH96.30-0.83
-0.85%
Lantheus Holdings
AWRE1.47-0.03
-2.00%
Aware
ELDN3.53-0.23
-6.12%
Eledon Pharmaceuticals